Home > Focus on Pain > Pain Treatments > News Regarding Pain Treatments In Development

News Regarding Pain Treatments In Development

10/13/2008	Acura Pharmaceuticals and King Pharmaceuticals Announce Positive Top Line Results of Key Clinical Study Assessing Abuse Liability
8/27/2008	Pain Therapeutics and King Pharmaceuticals Develop a New Abuse-Resistant Prescription Pain Medication
8/19/2008	Pain Therapeutics and King Pharmaceuticals Announce Final Data of Remoxy Phase III Study at World Pain Congress in Scotland
8/12/2008	FDA Accepts Remoxy® New Drug Application and Grants Priority Review
6/17/2008	Acurox™ Tablets Meet Primary Endpoint In Pivotal Phase III Study
6/10/2008	Pain Therapeutics and King Pharmaceuticals Announce Submission Of New Drug Application for Remoxy™
5/27/2008	King Pharmaceuticals Exercises Option to License Third Opioid Product Utilizing Acura's AVERSION® Technology
4/24/2008	King Pharmaceuticals and Acura Pharmaceuticals Announce Completion of Patient Enrollment For Pivotal Phase III Clinical Trial Evaluating Acurox™
12/6/2007	Remoxy™ Meets Primary Endpoint in Pivotal Phase III Study
10/31/2007	King Pharmaceuticals And Acura Pharmaceuticals Enter Agreement To Develop And Commercialize Immediate Release Pain Medicines Utilizing Acura's Aversion® (Abuse-Deterrent) Technology
7/11/2007	Patient Recruitment Completed For Pivotal Phase III Study of Remoxy™